Cardiovascular Revascularization Medicine : Including Molecular Interventions
Overview
Cardiovascular Revascularization Medicine : Including Molecular Interventions is a scientific journal, published by Elsevier since 2005 in English. The journal's country of origin is United States and its primary focus area is cardiology & vascular diseases.
Details
Details
Abbr.
Cardiovasc Revasc Med
Publisher
Elsevier
Start
2005
End
Continuing
Frequency
Quarterly
p-ISSN
1553-8389
e-ISSN
1878-0938
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 8115
44
SJR / Ranks: 8999
493
CiteScore / Ranks: 8566
3.00
Recent Articles
1.
Kumar S, Kearney K, Chung C, Elison D, Steinberg Z, Lombardi W, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40087130
Background: The use of plaque modification techniques during percutaneous coronary interventions (PCI) has increased. However, these procedures are linked to higher contrast volume and hypotensive episodes, which are risk factors...
2.
Ramesh P, Zghouzi M, Bista R, Patel N, Ezenna C, Paul T, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40087129
Background: Chronic Limb Threat Ischemia (CLTI) is a severe form of peripheral arterial disease characterized by various symptoms including nonhealing wounds, ulcers and gangrene ultimately leading to a possible amputation....
3.
Sia J, Kervinen K, Ylitalo A, De Bruyne B, Niemela M, Airaksinen J, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40082139
Objectives: The aim of this study was to compare 10-year clinical outcomes of titanium-nitride-oxide-coated (TiNO)-stent versus permanent polymer everolimus-eluting (EES), for the primary endpoint of major adverse cardiac events (MACE)...
4.
Borovac J, Schwarz K, Qureshi A, DAmario D, Milasinovic D, Will M, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40082138
Background: The impact of timing of invasive coronary angiography (ICA) and management strategies on in-hospital outcomes among unselected all-comers with non-ST-segment elevation myocardial infarction (NSTEMI) presents an equipoise in clinical...
5.
Chan N, Agrawal A, Arockiam A, Majid M, Haroun E, Shah A, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40082137
Aortic stenosis (AS) is the most common form of valvular heart disease in older adults requiring intervention. Severe symptomatic AS, if left untreated, is typically associated with a poor prognosis....
6.
Hansen K, Maehara A, Troan J, Noori M, Hougaard M, Ellert J, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40074646
Background: Lumen reduction after bioresorbable scaffold implantation has been reported. This study aimed to assess the influence of pre-dilatation with a scoring balloon versus a standard non-compliant balloon prior to...
7.
Dawson L, Wong C, Amponsah D, Fearon W
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40069013
No abstract available.
8.
Vijayvergiya R, Bose A, Sharma N, Kumar B, Sihag B, Gupta A
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40050142
Drug-coated balloons (DCB) have evolved as an alternative to drug-eluting stents in coronary interventions without the addition of an extra metal layer while delivering antiproliferative drugs. However, the delivery of...
9.
Bresha J, Hug K, Byrne R, Lahu S, Cassese S, Colleran R, et al.
Cardiovasc Revasc Med
. 2025 Mar;
PMID: 40050141
Background: The use of a non-drug eluting coronary stent with a thromboresistant and pro-healing coating may result in long term advantages in comparison to FDA approved drug eluting stents (DES)....
10.